The When Everyone Survives Foundation was founded to advance cures and treatment for leukemia through support for innovative research.
To that end, the foundation has issued its 2018 Request for Proposals for leukemia research. One-year grants of up to $50,000 will be awarded in support of innovative laboratory, translational, or clinical research related to acute leukemia. Renewal of initial research support may be considered for one or more additional years based on productivity.
New and established investigators are eligible to apply.
The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications to support screening of target-based pharmaceutical libraries to identify candidate therapeutics against select eukaryotic pathogens and subsequent preclinical development activities.
Supported by the NIH Common Fund (Common Fund) Science of Behavior Change (SOBC) Program, this Funding Opportunity Announcement (FOA) solicits competitive revision (formerly known as a competitive supplement) applications to NIH-supported clinical trials awarded as research project R34 grants. The goal of the SOBC Program is to advance a mechanisms-focused, experimental medicine approach to behavior change research. Funded projects in the SOBC Research Network (https://commonfund.nih.gov/behaviorchange/fundedresearch) have developed experimental manipulations, assays, and/or measures (hereafter referred to as assays for brevity) to support an experimental medicine approach to behavior change research. The SOBC Measures Repository is accessible from the SOBC Research Network Open Science Framework (OSF) page at https://osf.io/zp7b4. The goal of this FOA is to accelerate the adaptation, validation, and translation of SOBC Research Network assays for use in ongoing clinical trials. This FOA calls for the integration of SOBC Research Network assays into active NIH-supported clinical trials of drugs, devices, procedures, or behavior modifications. As such, the active NIH-supported clinical trial used to respond to this FOA does not have to be a behavior change trial or identify behavior change as a primary outcome. The integration of SOBC Research Network assays into ongoing clinical trials will accelerate the development of interventions and experimental manipulations that have been shown to engage specific mechanisms of behavior change and the development of assays that verify engagement of those behavior change targets.
The PRMRP Investigator-Initiated Research Award (IIRA) is intended to support studies that
will make an important contribution toward research and/or patient care for a disease or
condition related to at least one of the FY19 PRMRP Topic Areas.
The rationale for a research idea may be derived from a laboratory discovery, population-based
studies, a clinician's first-hand knowledge of patients, or anecdotal data. Applications must
include relevant data that support the rationale for the proposed study. These data may be
unpublished or from the published literature